These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study.
    Author: Meloni G, Foà R, Tosti S, Vignetti M, Gavosto F, Mandelli F.
    Journal: Haematologica; 1990; 75(6):502-5. PubMed ID: 2098290.
    Abstract:
    Five patients with lymphoid blastic transformation of chronic myeloid leukemia have been treated with IL2 associated with Vincristine (VCR) plus Prednisone (PDN). Our study indicates that IL2 may be employed in the management of this disease without excessive toxicity at the higher doses in hospitalized patients and at the lower doses as outpatients. Concerning the therapeutic efficacy, our preliminary results indicate that IL2 might be useful in enhancing the chemosensitivity of the leukemic blasts. It remains to be seen if this will result in a rapid return to the CP and in a prolongation of survival.
    [Abstract] [Full Text] [Related] [New Search]